My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 271

    1.

    Central nervous system neuropeptide Y signaling modulates VLDL triglyceride secretion.

    Stafford JM, Yu F, Printz R, Hasty AH, Swift LL, Niswender KD.

    Diabetes. 2008 Jun;57(6):1482-90. Epub 2008 Mar 10.PMID: 18332095 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Selective antagonism of the NPY Y5 receptor does not have a major effect on feeding in rats.

    Turnbull AV, Ellershaw L, Masters DJ, Birtles S, Boyer S, Carroll D, Clarkson P, Loxham SJ, McAulay P, Teague JL, Foote KM, Pease JE, Block MH.

    Diabetes. 2002 Aug;51(8):2441-9.PMID: 12145156 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats.

    Vettor R, Zarjevski N, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B.

    Diabetologia. 1994 Dec;37(12):1202-8.PMID: 7895949 [PubMed - indexed for MEDLINE]Related articles

    4.

    Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors.

    Henry M, Ghibaudi L, Gao J, Hwa JJ.

    Obes Res. 2005 Jan;13(1):36-47.PMID: 15761161 [PubMed - indexed for MEDLINE]Related articles

    5.

    Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism.

    Raposinho PD, Pierroz DD, Broqua P, White RB, Pedrazzini T, Aubert ML.

    Mol Cell Endocrinol. 2001 Dec 20;185(1-2):195-204.PMID: 11738809 [PubMed - indexed for MEDLINE]Related articles

    6.

    Selective activation of central NPY Y1 vs. Y5 receptor elicits hyperinsulinemia via distinct mechanisms.

    Gao J, Ghibaudi L, Hwa JJ.

    Am J Physiol Endocrinol Metab. 2004 Oct;287(4):E706-11. Epub 2004 Jun 8.PMID: 15187000 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Characterization of neuropeptide Y (NPY) Y5 receptor-mediated obesity in mice: chronic intracerebroventricular infusion of D-Trp(34)NPY.

    Mashiko S, Ishihara A, Iwaasa H, Sano H, Oda Z, Ito J, Yumoto M, Okawa M, Suzuki J, Fukuroda T, Jitsuoka M, Morin NR, MacNeil DJ, Van der Ploeg LH, Ihara M, Fukami T, Kanatani A.

    Endocrinology. 2003 May;144(5):1793-801.PMID: 12697685 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Chronic central melanocortin-4 receptor antagonism and central neuropeptide-Y infusion in rats produce increased adiposity by divergent pathways.

    Baran K, Preston E, Wilks D, Cooney GJ, Kraegen EW, Sainsbury A.

    Diabetes. 2002 Jan;51(1):152-8.PMID: 11756335 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Selective dependence of intracerebroventricular neuropeptide Y-elicited effects on central glucocorticoids.

    Zakrzewska KE, Sainsbury A, Cusin I, Rouru J, Jeanrenaud B, Rohner-Jeanrenaud F.

    Endocrinology. 1999 Jul;140(7):3183-7.PMID: 10385413 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Adrenalectomy prevents the obesity syndrome produced by chronic central neuropeptide Y infusion in normal rats.

    Sainsbury A, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B.

    Diabetes. 1997 Feb;46(2):209-14.PMID: 9000696 [PubMed - indexed for MEDLINE]Related articles

    11.

    Intracerebroventricular neuropeptide Y infusion precludes inhibition of glucose and VLDL production by insulin.

    van den Hoek AM, Voshol PJ, Karnekamp BN, Buijs RM, Romijn JA, Havekes LM, Pijl H.

    Diabetes. 2004 Oct;53(10):2529-34.PMID: 15448080 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Estimated liver weight is directly related to hepatic very low-density lipoprotein-triglyceride secretion rate in men.

    Tsekouras YE, Magkos F, Kavouras SA, Panagiotakos DB, Sidossis LS.

    Eur J Clin Invest. 2008 Sep;38(9):656-62.PMID: 18837742 [PubMed - indexed for MEDLINE]Related articles

    13.

    Viral mediated neuropeptide Y expression in the rat paraventricular nucleus results in obesity.

    Tiesjema B, la Fleur SE, Luijendijk MC, Brans MA, Lin EJ, During MJ, Adan RA.

    Obesity (Silver Spring). 2007 Oct;15(10):2424-35.PMID: 17925468 [PubMed - indexed for MEDLINE]Related articles

    14.

    Intracerebroventricular infusion of neuropeptide Y modulates VIP secretion in the fasting conscious dog.

    Anastasiou OE, Yavropoulou MP, Kesisoglou I, Kotsa K, Yovos JG.

    Neuropeptides. 2009 Feb;43(1):41-6. Epub 2008 Dec 5.PMID: 19058848 [PubMed - indexed for MEDLINE]Related articles

    15.

    Chronic intracerebroventricular insulin attenuates the leptin-mediated but not alpha melanocyte stimulating hormone increase in sympathetic and cardiovascular responses.

    Dunbar JC, Lu H.

    Brain Res Bull. 2000 May 15;52(2):123-6.PMID: 10808082 [PubMed - indexed for MEDLINE]Related articles

    16.

    Intracerebroventricular neuropeptide Y acutely influences glucose metabolism and insulin sensitivity in the rat.

    Marks JL, Waite K.

    J Neuroendocrinol. 1997 Feb;9(2):99-103.PMID: 9041362 [PubMed - indexed for MEDLINE]Related articles

    17.

    Chronic intracerebroventricular administration of anti-neuropeptide Y antibody stimulates starvation-induced feeding via compensatory responses in the hypothalamus.

    Ishii T, Muranaka R, Tashiro O, Nishimura M.

    Brain Res. 2007 May 4;1144:91-100. Epub 2007 Jan 31.PMID: 17320051 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effect of long-term administration of probucol on triglyceride turnover in rats.

    Yoshino G, Matsushita M, Maeda E, Nagata K, Naka Y, Murata Y, Hirano T, Kazumi T.

    Coron Artery Dis. 1994 Jan;5(1):67-72.PMID: 8136934 [PubMed - indexed for MEDLINE]Related articles

    19.

    Leptin and neuropeptide y have opposing modulatory effects on nucleus of the solitary tract neurophysiological responses to gastric loads: implications for the control of food intake.

    Schwartz GJ, Moran TH.

    Endocrinology. 2002 Oct;143(10):3779-84.PMID: 12239088 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Hemodynamic consequences of neuropeptide Y-induced obesity.

    Correia ML, Morgan DA, Sivitz WI, Mark AL, Haynes WG.

    Am J Hypertens. 2002 Feb;15(2 Pt 1):137-42.PMID: 11865825 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity